Prices are checked against each store and labelled with when.
It checks today's price at every store, compares the alternatives and answers in about a minute.
Tirzepatide is a once-weekly subcutaneous injection that acts on both GIP and GLP-1 receptors. It is prescribed mainly for type 2 diabetes and, in some presentations, for chronic weight management in people with obesity or overweight plus related conditions. It lowers blood sugar, slows appetite and increases fullness by acting on the central nervous system. It works best alongside a balanced diet and regular activity, and it needs a doctor's supervision because of gastrointestinal side effects such as nausea and constipation.
In stockReturn policy
Tirzepatide is a medication that acts as a dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. By activating both receptors, it helps regulate blood sugar levels. It also increases the feeling of fullness and reduces appetite by acting on the central nervous system.
It is mainly prescribed for managing type 2 diabetes. In certain presentations, it is also used for chronic weight management in patients with obesity or overweight who have related conditions. It is usually given as a once-weekly subcutaneous injection.
Its use should be prescribed and monitored by a health professional. Gastrointestinal side effects, such as nausea or constipation, can occur. It works best alongside lifestyle changes such as a balanced diet and regular physical activity. A medical evaluation is needed first to determine whether it suits the patient's health profile.